Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

Author: Sullivan S.D.  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.22, Iss.4, 2004-01, pp. : 257-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content